Management Team
Jean Rivier, Ph.D., Founder
- The Dr. Frederik Paulsen Chair in Neurosciences, Professor, The Salk Institute for Biological Studies
- Co-Discoverer of the CRF peptides and receptors
- Co-Discoverer of Degarelix, recently approved for the treatment of advanced prostate cancer (Ferring)
- Five peptide drugs on the market: GnRH, histrelin, Nal-Glu antagonist, somatostatin, and a growth hormone releasing factor
- Published > 650 publications in peptide drug design
- Co-founder of American Peptide Society
- Co-inventor of > 120 patents
- Studied under Nobel Laureate Roger Guillemin, the grandfather of neuro-endocrinology
George Nicola, Ph.D., MBA, Chief Business Officer
- PhD in Biochemistry from the Medical University of South Carolina
- MBA from the Rady School of Management, University of California San Diego
- Postdoctoral Fellow at The Scripps Research Institute, and was awarded a Research Scholar Fellowship from the American Cancer Society in 2007
- Held an appointment as Adjunct Professor of Chemistry at the University of San Diego
- Project Scientist at the Skaggs School of Pharmacy at UCSD
